Erythropoietin
Brands containing Erythropoietin, food notes, and the most important drug interactions.
BRANDS
11- DROPOETIN 2000 IU/0,2 ML SC/IV ENJEKSIYON ICIN COZELTI ICEREN KULLANIMA HAZIR 6 SIRINGAbarcode: 8699580950014
- DROPOETIN 3000 IU/0,3 ML SC/IV ENJEKSIYON ICIN COZELTI ICEREN KULLANIMA HAZIR 6 SIRINGAbarcode: 8699580950021
- DROPOETIN 4000 IU/0,4 ML SC/IV ENJEKSIYON ICIN COZELTI ICEREN KULLANIMA HAZIR 6 SIRINGAbarcode: 8699580950038
- EPO-T 3000 IU/0,3 ML IV ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTOR (6 ADET)barcode: 8699844952198
- EPOBEL 10000 IU/1 ML I.V. /S.C. STERIL ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTORbarcode: 8699262950356
- EPOBEL 3000 IU/0,9 ML I.V. /S.C. STERIL ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTOR 6 ENJEKTORbarcode: 8699262950257
- EPOBEL 4000 IU/0,4 ML IV STERIL 6 KULLANIMA HAZ. ENJ.barcode: 8699262950271
- EPOBEL 5000 IU/0,5 ML IV STERIL 6 KULLANIMA HAZ. ENJ.barcode: 8699262950295
- EPORON 10000 IU/1,0 ML KULLANIMA HAZIR 5 ENJEKTORbarcode: 8699769950187
- EPORON 4000 IU/0,4 ML KULLANIMA HAZIR 6 ENJEKTORbarcode: 8699769950163
- NEORECORMON 10000 IU/0,6ML 6 HAZIR SIRINGAbarcode: 8699505952499
FOOD NOTES
1Administer iron supplement. When initiating an erythropoiesis-stimulating agent, evaluate iron stores and start iron supplementation if indicated. Most patients with chronic kidney disease require iron supplementation while taking an erythropoiesis-stimulating agent.
Template translation
MOST IMPORTANT INTERACTIONS
first 10 of 50- CetuximabMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.
Expert view
- Denileukin diftitoxMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.
Expert view
- 10-hydroxycamptothecinMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 10-hydroxycamptothecin.
Expert view
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.
Expert view
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.
Expert view
- 2-MethoxyestradiolMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-Methoxyestradiol.
Expert view
- 3,4-Dihydroxybenzoic AcidMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 3,4-Dihydroxybenzoic Acid.
Expert view
- 5'-S-methyl-5'-thioadenosineMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 5'-S-methyl-5'-thioadenosine.
Expert view
- 6-O-benzylguanineMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 6-O-benzylguanine.
Expert view
- 7-HydroxystaurosporineMODERATE
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-Hydroxystaurosporine.
Expert view